BIA
AAPG

Bell Investment Advisors’s Ascentage Pharma AAPG Stock Holding History

Bell Investment Advisors’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67
Closed -$1.76K – 1958
2025
Q4 		$1.76K Hold
67
– – ﹤0.01% 1387
2025
Q3 		$2.62K Hold
67
– – ﹤0.01% 1224
2025
Q2 		$2.64K Buy
+67
New +$1.76K ﹤0.01% 1254

Other funds holding AAPG

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Bell Investment Advisors's AAPG Position: Q1 2026 in Review

Bell Investment Advisors sold out of Ascentage Pharma (AAPG) in Q1 2026, closing a stake of 67 shares — an estimated $1.76K sold.

Bell Investment Advisors first reported a position in AAPG in Q2 2025 and held it in 3 quarters. The position peaked at $2.64K in Q2 2025. 7 funds tracked by Wall St. Rank hold AAPG as of Q1 2026.

  • Bell Investment Advisors reported no remaining Ascentage Pharma position as of Q1 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 67 Ascentage Pharma shares in Q1 2026, an estimated $1.76K.
  • Bell Investment Advisors first reported a position in Ascentage Pharma in Q2 2025 and held it in 3 quarters.
  • Bell Investment Advisors's Ascentage Pharma position peaked at $2.64K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Ascentage Pharma as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.